CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Zai Lab Limited

ZLAB
$2.97BMid Cap

Next catalyst

PDUFANov 30, 2026in 8 days

povetacicept

immunoglobulin A nephropathy (IgAN)

Get an email about ZLAB's next catalysts

Track Zai Lab (ZLAB) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 2 more upcoming events in our data (Phase 3 readout, Phase 2 readout).See the timeline

Catalyst Timeline

3 upcoming, 1 past

PDUFANext

FDA PDUFA Date povetacicept (accelerated)

Nov 30, 2026povetacicept

For immunoglobulin A nephropathy (IgAN). BLA filing. Extracted from SEC filing: EX-99.1

Source
Phase 3

ZL-1109 (VRDN-003) Phase 3 Est. Readout

Q1 2027~QZL-1109 (VRDN-003)99

Primary completion for ZL-1109 (VRDN-003) trial (NCT07211776) in Thyroid Eye Disease (TED)

Source
Phase 2

ZL-1310 Phase 2 Est. Readout

August 2027~ZL-1310112

Primary completion for ZL-1310 trial (NCT06885281) in Solid Tumors

Source

Upcoming FDA decisions

How ZLAB's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical Preparations🇺🇸North AmericaSHANGHAI1.9K employees
Drug Pipeline

Frequently asked questions

What is in Zai Lab Limited's drug pipeline?→

CatalystAlert tracks 11 drug candidates in Zai Lab Limited's (ZLAB) pipeline across Phase 3, Phase 2. Its lead program is ZL-1109 (VRDN-003) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Zai Lab Limited's next FDA catalyst?→

Zai Lab Limited's (ZLAB) next tracked catalyst is a PDUFA date expected Nov 30, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track ZLAB biotech catalysts?→

Add ZLAB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Zai Lab Limited's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply